ImmunoPrecise Antibodies Ltd. submitted a Form 6-K filing on September 26, 2024, reporting compliance with SEC regulations. The filing indicates that annual reports will be filed under Form 20-F.
AI Assistant
IMMUNOPRECISE ANTIBODIES LTD
2024
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.